In December 2019 the Coronavirus disease-2019 COVID-19 virus has emerged in Wuhan China. In this research the first resolved COVID-19 crystal structure main protease was targeted in a virtual screening study by of FDA approved drugs dataset. In addition a knowledge gap in relations of COVID-19 with the previously known fatal Coronaviruses CoVs epidemics SARS and MERS CoVs was covered by investigation of sequence statistics and phylogenetics. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.